White & Case Advises Recipharm AB (Publ) on €100 Million Acquisition of Corvette Group Pharmaceutical Services | White & Case LLP International Law Firm, Global Law Practice
White & Case Advises Recipharm AB (Publ) on €100 Million Acquisition of Corvette Group Pharmaceutical Services

White & Case Advises Recipharm AB (Publ) on €100 Million Acquisition of Corvette Group Pharmaceutical Services

Global law firm White & Case LLP has advised Recipharm AB (publ) on the acquisition of Corvette Group Pharmaceutical Services S.p.A., previously controlled by the Italian private equity group LBO Italia Investimenti S.r.l.

The equity consideration for the purchase is around €100 million, with the deal expected to close on October 1, 2014.

Recipharm, a pharmaceutical contract development and manufacturing organisation, is a Sweden-based company listed on Nasdaq OMX Stockholm. The Corvette Group is the parent company of firms supplying high value added services to the pharmaceutical industry.

The White & Case team which advised Recipharm was led by partners Darragh Byrne (Stockholm) and Ferigo Foscari (Milan) with support from associates Christian Reineby (Stockholm), Alessandro Seganfreddo and Angelica Longanesi Cattani (both Milan).

Press Contact
For more information please speak to your local media contact.